AZGP1 and posterior cortical atrophy: However, there are also proteomics studies that have observed the opposite trend of AZGP1 in tissue [39], seminal plasma [65], serum [66], and urine of PCa patients, showing predictive power as a solo and as a panel biomarker, together with PSA [67].